An open-label phase 2 trial of entospletinib (GS-9973), a selective spleen tyrosine kinase inhibitor, in chronic lymphocytic leukemia

出版年份 2015 全文链接

标题

作者

关键词

出版物

Volume 125, Issue 15, Pages 2336-2343

出版商

American Society of Hematology

发表日期

2015-02-20

DOI

10.1182/blood-2014-08-595934

Discuss science. Find collaborators. Network.

Join a conversation

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started